Utilities, Consumer...
Health Care: Drugs
Idenix Pharmaceuticals Inc. (IDIX: NASDAQ)
$10.93 -0.20 | -1.80%
02/10/12 - 09:55 AM ET
101.75K / 1.77M
Vol / Avg. Vol:11.02 / 11.13
Open / Prev. Close:10.90 - 11.08
Today's Range:2.67 - 15.25
52 Wk Range:49.50%
Performance YTD:TheStreet Rating:
Portfolios with IDIX
- Portfolio NameUser Type
- Contributor3 Stocks Riding a 2012 M&A ...
- Contributor5 Stocks Under-$10 Setting ...
- Contributor13 Biotech Stocks Bought an...
- ProSeth Klarman - Baupost Group
- Contributor10 Hep C Stocks on Wall Str...
- UserLong Term Stock Picks by Co...
- Contributor11 Biotech Stocks Loved or ...
- Userinsider buying
- UserBioTech
- UserPART 7 JPMorgan 28th Annual...
Latest IDIX Headlines from TheStreet
- 3 Industries and 3 Stocks Riding a 2012 M&A Boom 02.06.12 | 12:02 pm
- Idenix Stock Falls On Unusually High Volume (IDIX) 02.03.12 | 01:02 pm
- Idenix Falls Casualty to Gilead Hep C Hoopla 02.03.12 | 11:02 am
- Idenix Stock Gaps Down On Today's Open (IDIX) 01.27.12 | 09:01 am
- Biotech Stock Mailbag: Vical, Hep C Drugs 01.27.12 | 07:01 am
- BioLineRx: Tuesday's Hot Hep C Drug Stock 01.24.12 | 11:01 am
- Idenix Pharma Buyout Likely: Survey 01.20.12 | 03:01 pm
- Biotech Stock Mailbag: Celldex, Hep C Bubble, Al Mann Anger 01.20.12 | 05:01 am
- Biotech Lessons Learned From JPM 2012 01.13.12 | 06:01 am
- J.P. Morgan Biotech Confab Live Chat 01.10.12 | 06:01 pm
Press Releases for IDIX
- Idenix Pharmaceuticals To Present At Two Upcoming Investor Conferences - PR Newswire 02.07.12 | 04:02 pm
- BioMed Realty Trust To Acquire Cambridge Place For $119 Million - PR Newswire 02.06.12 | 05:02 pm
- Idenix Announces Removal Of The Partial Clinical Hold On HCV Nucleotide Inhibitor, IDX184 - PR Newswire 02.03.12 | 08:02 am
- Idenix Reports Advancement Of HCV Development Pipeline - PR Newswire 01.09.12 | 07:01 am
- Idenix Reports Positive Interim Data For HCV Nucleotide Inhibitor, IDX184 - PR Newswire 01.09.12 | 07:01 am
- Idenix Pharmaceuticals To Present At The 30th Annual J.P. Morgan Healthcare Conference - PR Newswire 01.03.12 | 08:01 am
- Idenix Pharmaceuticals Prices Public Offering Of Common Stock - PR Newswire 11.16.11 | 08:11 am
- Idenix Pharmaceuticals Announces Proposed Public Offering Of Common Stock - PR Newswire 11.15.11 | 04:11 pm
- Idenix To Host Conference Call Discussing Third Quarter And Nine Month 2011 Financial Results And Announces Presentations At The American Association For The Study Of Liver Diseases Meeting (AASLD) - PR Newswire 10.26.11 | 04:10 pm
- Idenix Pharmaceuticals To Present At An Upcoming Investor Conference - PR Newswire 09.20.11 | 04:09 pm
Partner Headlines for IDIX
- Company News for February 6, 2012 - Corporate Summary - Zacks 02.06.12 | 10:02 am
- Momentum Trading: These 6 Stocks Are Up More Than 50% Already in 2012 - Benzinga 01.27.12 | 03:01 pm
- Benzinga's M&A Chatter for Friday January 20, 2012 - Benzinga 01.20.12 | 06:01 pm
- 10 Biotech Stocks With Strong Corporate Governance - Seeking Alpha 01.18.12 | 09:01 am
- 10 Stocks That Made New Highs On Friday: Hedging Costs - Seeking Alpha 01.15.12 | 07:01 am
- Afternoon Movers; Markets Moved Lower - Benzinga 01.13.12 | 04:01 pm
- Analyzing 5 Biotech Stocks And Their Takeover Potential - Seeking Alpha 01.13.12 | 08:01 am
- Afternoon Movers; Markets Moved Higher - Benzinga 01.09.12 | 04:01 pm
- Forget Dendreon, Inhibitex is the New Biotech Success Story - Benzinga 01.09.12 | 01:01 pm
- Idenix Pops 40% on Pipeline Development - Benzinga 01.09.12 | 09:01 am
